Icahn School of Medicine at Mount Sinai and The New York Academy of Medicine (NYAM) announced the formation of a new partnership to jointly study and address a number of significant health issues and policies that impact the lives of people who live in urban areas. NYAM is an historic and independent institution that has been advancing the health of people living in cities since its founding in 1847.
Mitral Valve Prolapse (MVP) is a common heart valve abnormality that affects up to 5 percent of the U.S. population. The mitral valve controls the flow of blood from the lungs to the main pumping chamber of the heart. MVP results from a degeneration of valve structure that leads to a regurgitation of blood backwards that can result in heart enlargement and weakening, as well as fatigue and shortness of breath.
The Icahn School of Medicine at Mount Sinai, and National Jewish Health, the nation’s leading respiratory hospital, based in Denver, Colorado, have created a partnership to advance patient care and research in respiratory and related diseases. The Mount Sinai–National Jewish Health Respiratory Institute is expected to open on the Icahn School of Medicine campus in July.
The Mount Sinai Health System recently established the Mount Sinai Institute of Technology (MSIT), with a $5 million grant from the New York City Economic Development Corporation (NYCEDC). As part of Icahn School of Medicine at Mount Sinai, MSIT will train students to develop technology-based solutions that improve human health, and serve as an incubator for transformative, cost-effective discoveries.
At Icahn School of Medicine at Mount Sinai’s recent SinaInnovations conference, two leaders with unparalleled success in building and managing winning teams delivered keynote addresses before standing-room only crowds in Stern Auditorium: Joseph Torre, the legendary former manager (and now Baseball Hall of Fame inductee) of the New York Yankees, and Rear Admiral Scott P. Moore, Deputy Commander Naval Special Warfare command (Navy SEALS).
The topic of “team science” took center stage at Icahn School of Medicine at Mount Sinai’s second annual SinaInnovations conference on Monday, November 18, and Tuesday, November 19. Hundreds of scientists, students, and participants from diverse industries gathered in Stern Auditorium for keynote addresses and panel discussions that examined how teamwork drives creativity. The conference also featured smaller breakout sessions run by leaders in academia and industry that explored topics such as scholarship and diversity within team science.
Vast amounts of data from genomic sequencing and electronic health records (EHRs) have the potential to radically improve the health of individual patients, but first, institutions must learn how to manage the data, and adopt uniform standards that allow them to share it.
This discussion took center stage at a Working Summit on Big Data hosted by The Atlantic in partnership with the Mount Sinai Health System on Wednesday, October 23, at The New York Palace Hotel. At a roundtable discussion, 24 policymakers, entrepreneurs, and health care leaders shared their thoughts and experiences in harnessing petabytes of data for use in improving human health.
Ten faculty members were named endowed professors at the 2013 Convocation Ceremony on Monday, September 30, an event that marks the beginning of the academic year for the Icahn School of Medicine at Mount Sinai. The honorees, renowned in their respective fields—including allergy and immunology, cancer research, neuroscience, nephrology, otolaryngology, translational genetics, and transplant immunology—comprised the largest group named at one time at Mount Sinai.